Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
|
AtriCure, Inc. (ATRC)
|
Add to portfolio |
|
|
|
| Price: |
$71.39
| | Metrics |
| OS: |
46.6
|
M
| |
-10
|
% ROE
|
| Market cap: |
$3.32
|
B
| |
-22
|
% ROIC
|
|
Net cash:
|
$116
|
M
| |
$2.49
|
per share
|
|
EV:
|
$3.21
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($31.0)
|
M
| |
|
|
|
EBIT
|
($42.7)
|
M
| |
|
|
| EPS |
($1.02)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 330.4 | 274.3 | 206.5 | 230.8 | 201.6 | 174.7 | 155.1 | 129.8 |
| Revenue growth | 20.4% | 32.8% | -10.5% | 14.5% | 15.4% | 12.6% | 19.5% | 20.8% |
| Cost of goods sold | 84.4 | 68.5 | 57.2 | 60.5 | 0.8 | 0.9 | 44.0 | 36.9 |
| Gross profit | 245.9 | 205.9 | 149.3 | 170.3 | 200.8 | 173.8 | 111.1 | 92.9 |
| Gross margin | 74.4% | 75.0% | 72.3% | 73.8% | 99.6% | 99.5% | 71.6% | 71.6% |
| Selling, general and administrative | 231.3 | 204.6 | 150.8 | 167.1 | 164.2 | 151.1 | 106.4 | 93.9 |
| Research and development | 57.3 | 48.5 | 43.1 | 41.2 | | | 35.8 | 25.7 |
| EBITA | -39.0 | -44.4 | -42.9 | -36.1 | 38.1 | 24.0 | -29.5 | -25.4 |
| EBITA margin | -11.8% | -16.2% | -20.8% | -15.6% | 18.9% | 13.8% | -19.0% | -19.6% |
| Amortization of intangibles | 3.7 | 2.9 | 1.7 | 1.9 | 1.5 | 1.4 | 1.6 | 1.3 |
| EBIT | -42.7 | -47.3 | -44.6 | -38.0 | 36.6 | 22.7 | -31.1 | -26.7 |
| EBIT margin | -12.9% | -17.2% | -21.6% | -16.5% | 18.2% | 13.0% | -20.1% | -20.6% |
| Pre-tax income | -46.2 | 50.4 | -48.0 | -35.0 | -20.9 | -26.9 | -33.3 | -27.2 |
| Income taxes | 0.3 | 0.2 | 0.1 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.4% | | | | | | |
| Net income | -46.5 | 50.2 | -48.2 | -35.2 | -21.1 | -26.9 | -33.3 | -27.2 |
| Net margin | -14.1% | 18.3% | -23.3% | -15.2% | -10.5% | -15.4% | -21.5% | -21.0% |
| |
| Diluted EPS | ($1.02) | $1.09 | ($1.14) | ($0.94) | ($0.62) | ($0.83) | ($1.05) | ($0.97) |
| Shares outstanding (diluted) | 45.7 | 46.0 | 42.1 | 37.6 | 34.1 | 32.4 | 31.6 | 28.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|